W. Gannon

发表

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine

Lawrence Tamarkin, S. Libutti, M. Walker, 2010, Clinical Cancer Research.

Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine.

S. Libutti, M. Walker, G. Paciotti, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary results of a phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine

S. Libutti, G. Paciotti, L. Myer, 2007 .

PRTX‐100 and methotrexate in patients with active rheumatoid arthritis: A Phase Ib randomized, double‐blind, placebo‐controlled, dose‐escalation study

E. Bernton, W. Gannon, W. Kramer, 2014, Clinical pharmacology in drug development.